Skip to content
Clinical Trials – home
Consorzio Oncotech
Sponsor

Consorzio Oncotech

Italy Via Sergio Pansini 5, 80131 Naples, Italy

About the sponsor

Consorzio Oncotech is involved in clinical research for metastatic renal cell carcinoma and oligometastatic renal cell carcinoma, with a focus on treatment strategies for patients eligible for local and systemic cancer control.

  • pembrolizumab in resectable metastatic kidney cancer
  • nivolumab and ipilimumab sequencing
  • axitinib intensification

The sponsor’s renal cancer portfolio centers on advanced disease management and therapeutic approaches for patients with limited metastatic burden.

About Specializations

Consorzio Oncotech runs clinical trials in conditions such as Metastatic renal cell carcinoma, Triple negative breast cancer, Breast cancer metastatic, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Consorzio Oncotech
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib
  • Sponsor:Consorzio Oncotech
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Palbociclib
  • Sponsor:Consorzio Oncotech
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Consorzio Oncotech

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.